The selection and design of blood collection tubes have emerged as critical factors in clinical chemistry, influencing both the integrity of analytes and the efficiency of laboratory workflows. Modern ...
MELBOURNE, Australia , Feb. 19, 2026 (GLOBE NEWSWIRE) -- Q-Sera Pty Ltd, an Australian venture-backed company, today announced the first product launch of its patented evacuated blood collection ...
Steripath ® Initial Specimen Diversion Device ®, a clinically proven solution, enables hospitals to meet the new goal of 1% blood culture contamination as published in CLSI's M47 Principles and ...
A laboratory technician places human blood samples on an automated testing line. This laboratory, which operates a fully automated system complete with advanced robotics, can test more than 50,000 ...
Dublin, March 05, 2026 (GLOBE NEWSWIRE) -- The "Blood Collection Devices Market by Product (Tubes (Plasma (EDTA, Heparin), Serum), Needles & Syringes, Blood Bags ...
Liquid biopsies have emerged as a powerful tool in modern medicine, enabling non-invasive detection and monitoring of diseases such as cancer. At the forefront of this revolution are the BD PAXgene ® ...
Q-Sera announces the first launch of blood collection tubes using its patented Rapclot technology in Japan, opening opportunities for additional global partnerships Melbourne, Australia – February 19, ...